These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1713245)

  • 1. Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects.
    Mailly F; Xu CF; Xhignesse M; Lussier-Cacan S; Talmud PJ; Davignon J; Humphries SE; Nestruck AC
    J Lipid Res; 1991 Apr; 32(4):613-20. PubMed ID: 1713245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.
    Feussner G; Scharnagl H; Scherbaum C; Acar J; Dobmeyer J; Lohrmann J; Wieland H; März W
    J Lipid Res; 1996 Aug; 37(8):1632-45. PubMed ID: 8864947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
    Minnich A; Weisgraber KH; Newhouse Y; Dong LM; Fortin LJ; Tremblay M; Davignon J
    J Lipid Res; 1995 Jan; 36(1):57-66. PubMed ID: 7706948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease.
    Kang AK; Jenkins DJ; Wolever TM; Huff MW; Maguire GF; Connelly PW; Hegele RA
    Mutat Res; 1997 Sep; 382(1-2):57-65. PubMed ID: 9360638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
    Wardell MR; Rall SC; Schaefer EJ; Kane JP; Weisgraber KH
    J Lipid Res; 1991 Mar; 32(3):521-8. PubMed ID: 1648586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of a human apolipoprotein E variant: E5 (Glu3----Lys3).
    Maeda H; Nakamura H; Kobori S; Okada M; Niki H; Ogura T; Hiraga S
    J Biochem; 1989 Apr; 105(4):491-3. PubMed ID: 2760009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.
    van den Maagdenberg AM; Weng W; de Bruijn IH; de Knijff P; Funke H; Smelt AH; Gevers Leuven JA; van't Hooft FM; Assmann G; Hofker MH
    Am J Hum Genet; 1993 May; 52(5):937-46. PubMed ID: 8488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
    Smit M; de Knijff P; van der Kooij-Meijs E; Groenendijk C; van den Maagdenberg AM; Gevers Leuven JA; Stalenhoef AF; Stuyt PM; Frants RR; Havekes LM
    J Lipid Res; 1990 Jan; 31(1):45-53. PubMed ID: 2313204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
    Wardell MR; Rall SC; Brennan SO; Nye ER; George PM; Janus ED; Weisgraber KH
    J Lipid Res; 1990 Mar; 31(3):535-43. PubMed ID: 2341812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the gene for apolipoprotein E5-Frankfurt (Gln81->Lys, Cys112->Arg) by polymerase chain reaction, restriction isotyping, and temperature gradient gel electrophoresis.
    Ruzicka V; März W; Russ A; Fisher E; Mondorf W; Gross W
    Electrophoresis; 1993 Oct; 14(10):1032-7. PubMed ID: 8125051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
    Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
    J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia.
    Marcil M; Vu H; Cui W; Dastani Z; Engert JC; Gaudet D; Castro-Cabezas M; Sniderman AD; Genest J; Cianflone K
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1619-25. PubMed ID: 16627811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia.
    Yamanouchi Y; Takano T; Hamaguchi H; Tokunaga K
    J Hum Genet; 2001; 46(11):633-9. PubMed ID: 11721882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human apolipoprotein E variant gene: apolipoprotein E7 (Glu244,245----Lys244,245).
    Maeda H; Nakamura H; Kobori S; Okada M; Mori H; Niki H; Ogura T; Hiraga S
    J Biochem; 1989 Jan; 105(1):51-4. PubMed ID: 2738044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.
    Pullinger CR; Malloy MJ; Shahidi AK; Ghassemzadeh M; Duchateau P; Villagomez J; Allaart J; Kane JP
    J Lipid Res; 1997 Sep; 38(9):1833-40. PubMed ID: 9323592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.
    de Knijff P; van den Maagdenberg AM; Stalenhoef AF; Leuven JA; Demacker PN; Kuyt LP; Frants RR; Havekes LM
    J Clin Invest; 1991 Aug; 88(2):643-55. PubMed ID: 1864973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.
    Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A
    Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.
    Hazzard WR; Warnick GR; Utermann G; Albers JJ
    Metabolism; 1981 Jan; 30(1):79-88. PubMed ID: 7464557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.